PositoAI/ US/ BioAge Labs, Inc.

BioAge Labs, Inc.

NasdaqGS: BIOA · Healthcare

Positivity Index

#1,497 / 6,774

Global

#339 / 4,000

United States

Positivity Score

22,681

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

BioAge Labs, Inc. — Overview & Financial Snapshot

BioAge Labs, Inc. (NasdaqGS: BIOA) is a Healthcare company, ranked #1,497 of 6,774 companies globally and #339 of 4,000 in United States on PositoAI, with a Positivity Score of 22,681. Its market capitalisation is ₹2,395.73 Cr ($253.81M), P/E ratio is -2.3 and P/B ratio is 0.68. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

P/B Ratio 0.68

P/E Ratio -2.3

D/E Ratio 0.01

ROE -28.21%

Owes vs Owns ? 0.06× Low $0.06 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-225.59$-2.39

Forward EPS ₹-236.27$-2.50

Beta 1.08

Market Cap ₹2,395.73 Cr$253.81M

What these numbers mean →

What does BioAge Labs, Inc. do?

What is BioAge Labs, Inc.'s P/E and P/B ratio?

BioAge Labs, Inc. has a P/E ratio of -2.3 and a P/B ratio of 0.68.

What is BioAge Labs, Inc.'s debt-to-equity ratio?

BioAge Labs, Inc. has a debt-to-equity ratio of 0.01.

How much does BioAge Labs, Inc. owe compared with what it owns?

BioAge Labs, Inc. owes $0.06 for every $1 it owns (balance sheet Jun 2026), which is low.

What is BioAge Labs, Inc.'s Positivity rank?

BioAge Labs, Inc. is ranked #1,497 of 6,774 companies globally and #339 of 4,000 in United States on PositoAI, with a Positivity Score of 22,681.

Does BioAge Labs, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for BioAge Labs, Inc..

Where can I read the latest news about BioAge Labs, Inc.?

Recent headlines about BioAge Labs, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does BioAge Labs, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of BioAge Labs, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.